ArticleFrontiers in immunology2021

Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells.

Jens Tijtgat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.